(NASDAQ: ICLR) Icon's forecast annual revenue growth rate of 1.32% is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 5.14%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.75%.
Icon's revenue in 2025 is $8,192,622,000.On average, 6 Wall Street analysts forecast ICLR's revenue for 2025 to be $630,880,364,479, with the lowest ICLR revenue forecast at $626,962,061,677, and the highest ICLR revenue forecast at $635,013,935,940. On average, 6 Wall Street analysts forecast ICLR's revenue for 2026 to be $645,584,826,991, with the lowest ICLR revenue forecast at $636,015,980,158, and the highest ICLR revenue forecast at $665,988,306,727.
In 2027, ICLR is forecast to generate $682,321,150,690 in revenue, with the lowest revenue forecast at $667,517,198,935 and the highest revenue forecast at $707,458,315,918.